Literature DB >> 7736396

Clinical significance of intratumoral blood flow in cervical carcinoma assessed by color Doppler ultrasound.

C Y Hsieh1, C C Wu, T M Chen, C A Chen, C L Chen, J F Wang, C F Chang, F J Hsieh.   

Abstract

BACKGROUND: Much evidence has suggested that vascular density reflects the clinical behavior of cancer. In this study, the intratumoral blood flow in cervical carcinomas was assessed by transvaginal color Doppler ultrasound, and its clinical significance was evaluated.
METHODS: Sixty-five patients with Stage Ib-IIb cervical carcinoma exhibiting visible cervical tumor by transvaginal ultrasound were enrolled. All patients were scheduled for radical hysterectomy and pelvic lymph node dissection. Transvaginal color Doppler ultrasound was performed before surgery to search for blood flow signals from the tumor and the main uterine artery. The corresponding arterial resistance index (RI) was calculated. Clinical and pathologic data were recorded. A cytokinetic study was performed by propidium iodide staining and flow cytometry. The human papillomavirus (HPV) status was assessed by polymerase chain reaction.
RESULTS: Intratumoral blood flow was detected by color Doppler ultrasound in 46.2% (30/65) of the tumors. Patients with detectable intratumoral blood flow exhibited significantly more pelvic lymph node metastasis (10/30 vs. 2/35, P = 0.005), a higher percentage of cancer cells in the S- + G2M-phase (30.02 +/- 18.54% vs. 19.35 +/- 11.21%, P < 0.005), and a higher prevalence of HPV infection (30/30 vs. 25/35, P = 0.001) when compared with those without intratumoral blood flow. No significant difference was observed concerning the patient's age, tumor size, clinical staging, histologic type, and DNA ploidy status between these two groups. Regression analysis of the intratumoral RI value on the S- + G2M-phase fraction showed linear regression (n = 30, r2 = 0.501, P < 0.01). The RI values of the main uterine artery showed no significant difference between these two groups.
CONCLUSION: The intratumoral blood flow by transvaginal color Doppler ultrasound correlated well with a higher proliferation index, higher incidence of HPV infection, and pelvic lymph node metastasis in cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7736396     DOI: 10.1002/1097-0142(19950515)75:10<2518::aid-cncr2820751018>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  The role of ultrasound in the assessment of uterine cervical cancer.

Authors:  Juan Luis Alcázar; Sara Arribas; José Angel Mínguez; Matías Jurado
Journal:  J Obstet Gynaecol India       Date:  2014-10-08

2.  Vascularity demonstrated by Doppler ultrasound and immunohistochemistry in invasive ductal carcinoma of the breast.

Authors:  E E Sterns; S SenGupta; F Saunders; B Zee
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Dual-Illumination Ultrasound/ Photoacoustic System for Cervical Cancer imaging.

Authors:  Maryam Basij; Andrei Karpiouk; Ira Winer; Stanislav Emelianov; Mohammad Mehrmohammadi
Journal:  IEEE Photonics J       Date:  2020-12-14       Impact factor: 2.443

4.  Neoangiogenesis in early cervical cancer: correlation between color Doppler findings and risk factors. A prospective observational study.

Authors:  Matias Jurado; Rosendo Galván; Rafael Martinez-Monge; Jesús Mazaira; Juan Luis Alcazar
Journal:  World J Surg Oncol       Date:  2008-11-25       Impact factor: 2.754

5.  Miniaturized phased-array ultrasound and photoacoustic endoscopic imaging system.

Authors:  Maryam Basij; Yan Yan; Suhail S Alshahrani; Hamid Helmi; Timothy K Burton; Jay W Burmeister; Michael M Dominello; Ira S Winer; Mohammad Mehrmohammadi
Journal:  Photoacoustics       Date:  2019-07-25

6.  Application Value of Color Doppler Ultrasound and Ultrasound Contrast in the Differential Diagnosis of Ovarian tumor.

Authors:  Haijing Zhang; Jinming Wang; Rui Guo
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.